Navigation Links
Nicholas buys ICI’s drug business for Rs 70 c

Pharmaceutical major Nicholas Piramal India Ltd. (NPIL) has acquired the pharmaceutical business of ICI (India) Ltd. For Rs 70 crore in an all-cash deal, on a going concern basis. The amount includes Rs 14 crore towards acquiring net current assets of ICI and Rs 1 crore to NPIL by ICI towards transaction costs. The deal includes ICI’s key brands and its manufacturing facility at Ennore, near Chennai, with 150 employees.//

Announcing the deal, Mr Ajay Piramal, Chairman, NPIL, said that with the latest acquisition, the company had become the number one player in the cardiovascular segment. ICI’s pharma sales amounted to Rs 69 crore in 2000-2001. This is the second acquisition by the company in the past two years. In 2000, it had acquired Rhone-Poulenc India.

It is also the latest in a series of acquisition by the company, vaulting it into the league of Rs 1,000-crore pharma firms.The acquisition of the ICI business brings with it key brands in the cardiovascular segment, such as Tenormin, Inderal, Zestril and Tenochlor, which will catapult NPIL to the number one position in the Rs 1,300-crore India cardiovascular market. The other players in the segment are Cipla, Zydus Cadila, Torrent Pharmaceuticals and Sun Pharmaceuticals.

Mr Piramal said, “This acquisition is significant for our presence in high-growth segments such as cardiovascular, central nervous system and critical care segment. The niche or speciality bulk drugs that are exported by the business have no competition from India and limited international competition.” ICI’s pharma business has about 357 employees, including a field force of 200.
'"/>




Page: 1

Related medicine news :

1. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
2. Argentine Meat Export business gets a jolt from Russia.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... New England ... Health Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls on Health ... Foundation for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a new ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
(Date:5/23/2017)... ... May 23, 2017 , ... Drs. ... on peri-implantitis in Las Vegas, NV, and the importance of treating ... disease consultation and leading care for peri-implantitis, with or without a referral. As ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, are now ... practicing in Mt. Pleasant, SC, with or without a referral. A full mouth reconstruction ... missing teeth in Charleston, SC. Those who suffer from gum disease, misaligned ...
(Date:5/23/2017)... Segundo, CA (PRWEB) , ... May 23, 2017 ... ... braces can now receive treatment using the SPEED System™ Orthodontics, with or without ... respected orthodontist in El Segundo, CA, who is skilled in providing ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
(Date:5/8/2017)... , May 8, 2017 MACRA ... transition from fee for service reimbursement. Black Book Research ... 1.       The Market for MIPS Compliance ... 77% of physician practices with 3 or more clinicians ... Solutions by Q4. "Given the magnitude of the changes, ...
(Date:5/6/2017)...  Hill-Rom Holdings, Inc. (NYSE: HRC), has begun a ... to its Welch Allyn campus. The ... more than 100 new jobs to Central ... a significant presence for more than 100 years. Hill-Rom,s ... large portion of which will be R&D and engineering ...
Breaking Medicine Technology: